ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
39 hedge funds and large institutions have $47.9M invested in Elevation Oncology in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
Holders
39
Holders Change
+12
Holders Change %
+44.44%
% of All Funds
0.62%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
18
Increased
8
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TCM
1
Tang Capital Management
San Diego,
California
|
$6.08M |
| 2 |
AC
2
Armistice Capital
New York
|
$3.64M |
| 3 |
3
Millennium Management
New York
|
$3.52M |
| 4 |
O
4
OrbiMed
New York
|
$2.28M |
| 5 |
ECM
5
ExodusPoint Capital Management
New York
|
$2.28M |
